Company Filing History:
Years Active: 1995-1997
Title: May T Griffin: Innovator in Antitumor Agents
Introduction
May T Griffin is a notable inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of two patents to her name, her work is recognized for its potential impact on cancer treatment.
Latest Patents
One of her latest patents involves Gem-dichlorocyclopropanes as antitumor agents. These compounds, specifically the Analog II derivatives, demonstrate antiproliferative activity toward MCF-7 cells in vitro. Notably, they are generally not reversed by estradiol and do not exhibit intrinsic estrogenicity, except for the hydroxyphenyl derivative known as Compound 30. The cyclopropane compounds have a specific formula, where X can be hydrogen or halogen atoms. The groups R1, R2, R3, and R4 can vary, including hydrogen atoms, alkyl groups, acyl groups, and aryl groups, among others. This innovative approach to cancer treatment highlights her expertise in medicinal chemistry.
Career Highlights
May T Griffin is currently associated with Research Corporation Technologies, Inc. Her work at this organization has allowed her to focus on the development of novel pharmaceutical compounds. Her contributions are paving the way for advancements in cancer therapies.
Collaborations
Some of her notable coworkers include Robert A Magarian and Joseph T Pento. Their collaborative efforts contribute to the innovative research environment at Research Corporation Technologies, Inc.
Conclusion
May T Griffin's work in developing antitumor agents showcases her dedication to advancing medical science. Her innovative patents reflect her commitment to improving cancer treatment options.